Chemical development and pharmaceutical services are offered by Chembricks.
Annual revenue $15,909 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Chembricks

Chembricks is a company. Chembricks offers products and services including Custom Synthesis and API Intermediates.

Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $15.91 K (USD)
    106.21
    as on Mar 31, 2022
  • Net Profit
    $82.36 (USD)
    230
    as on Mar 31, 2022
  • EBITDA
    $110.07 (USD)
    229.28
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Chembricks

Chembricks offers a comprehensive portfolio of products and services, including Custom Synthesis and API Intermediates.

Product name locked
Category locked
Primary

Custom synthesis services are provided for research labs and pharma companies, focusing on heterocyclic compounds and natural products.

Product name locked
Category locked
Locked

API intermediates are developed and manufactured to support the pharmaceutical industry through chemical development processes.

Funding Insights of Chembricks

Premium access

Detailed funding history for Chembricks

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Chembricks

Investments
Premium access

Investment portfolio details for Chembricks

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Chembricks

Premium access

Detailed financials for Chembricks

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Chembricks Comparisons

Chembricks Primary company
Description
Chemical development and pharmaceutical services are offered...
Location
-
Founded Year
-
Annual Revenue
$15.91 K (USD)
Net Profit
$82.36 (USD)
EBITDA
$110.07 (USD)
Employees
Not available
Premium access

Peer comparison for Chembricks

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Chembricks

Premium access

Detailed competitors of Chembricks

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Chembricks

Premium access

Complete news archive for Chembricks

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chembricks

Annual revenue of Chembricks is $15.91K as on Mar 31, 2022.

Chembricks is recognized as a research-driven pharmaceutical company that was established in 2019, providing services in the chemical development of heterocyclic compounds, natural products, and API intermediates. Support is extended to manufacturers, medchem groups, and chemical development teams globally, with capabilities ranging from milligrams to kilograms. Services are delivered on FFS and FTE models, emphasizing collaboration with pharmaceutical, biotechnology, and chemical industries to meet research and healthcare demands effectively.

Chembricks offers Custom Synthesis and API Intermediates.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available